Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Cidara Therapeutics to Participate in The Citizens Life Sciences Conference
-
IBN Announces Latest Episode of The MiningNewsWire Podcast featuring Frank R. Hallam, CEO of Platinum Group Metals Ltd.
-
Greenridge Exploration Completes Airborne MobileMT Survey at the Sabre Uranium Project in Athabasca Basin, Saskatchewan
-
Snyk Joins Coalition for Secure AI (CoSAI) to Champion Safe, Responsible AI Development
-
INNEOVA Holdings Limited Strengthens Engineering Capabilities and Accelerates Growth in Sustainable Solutions with the Acquisition of INNEOVA Engineering Pte. Ltd.
-
Indonesia Energy Files 2024 Annual Report and Provides an Update on Operations and Planned Drilling During the Remainder of 2025
-
Actinogen provides pivotal Alzheimer’s trial enrolment update and other business news
-
XING Mobility Launches BBx48: Industry-First Immersion-Cooled BBU That Rewrites the Rules of Data Center Backup Power
-
Altamira Therapeutics Provides Business Update, Reports Full Year 2024 Financial Results
-
Banco Santander-Chile Announces First Quarter 2025 Earnings
-
CTS Announces First Quarter 2025 Results
-
NOVAGOLD Announces Date of its 2025 Virtual Annual Meeting of Shareholders
-
Intercept Announces Data to be Presented at Digestive Disease Week 2025
-
authID to Report First Quarter 2025 Financial Results on May 13, 2025
-
FuelCell Energy Announces Leadership Transition: Mike Hill Named Chief Commercial Officer to Replace Departing Mark Feasel
-
Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems
-
LeddarTech to Announce Second Quarter 2025 Financial Results and Host Investor and Business Update Call on May 14, 2025
-
Vertex Announces Strategic Investment in AI Tax Compliance Startup Kintsugi
-
ClearlyRated Acquires Client Savvy, Bolsters Customer Experience Leadership in Professional Services Market
-
NewAmsterdam Pharma to Present New Clinical and Preclinical Data at 93rd EAS Congress
-
Verrica Pharmaceuticals to Participate in the Citizens Life Sciences Conference in New York
-
Concerns about Mental Health Medication Side Effects Remain a Barrier to Getting Help for Those Diagnosed with Depression and Anxiety, According to the GeneSight Mental Health Monitor
-
Global-e to Announce Financial Results for the First Quarter 2025 on May 14, 2025
-
Solid Biosciences to Participate at The Citizens Life Sciences Conference
-
Enterprises to Redefine Cyber Resilience with Rackspace and Rubrik
-
Kestra Medical Technologies to Participate in Upcoming Investor Conferences
-
Westwood Celebrates One-Year Anniversary of Westwood Salient Enhanced Energy Income ETF (NYSE: WEEI)
-
EDR Killers: What They Are, Why They Matter, and How Organizations Can Stay Protected
-
Safe Harbor Financial Expands Executive Leadership Team with Appointments of Jeffrey Kay as SVP of Marketing and Dominic Marella as VP of Business Development
-
trivago Delivers 22% Revenue Growth and Raises Full-Year Guidance
-
Kymeta Supercharges Leadership with Top Defense, Space and Tech Experts to Tackle Global Security Challenges
-
VCI Global’s High-Growth Fintech Startup Credilab Secures Strategic Investment from Dubai Fund
-
UAB “Atsinaujinančios energetikos investicijos” publishes its factsheet for the first quarter of 2025
-
Gain Therapeutics Announces Oral Poster Presentation at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders
-
First AI-Driven Cognitive and Speech Therapy Platform for Spanish, English-Speaking Indian Communities
-
Charging Robotics Installs Wireless EV Charging System in Automatic Parking Facility
-
Appendix 4C – Q3 FY25 Quarterly Cash Flow Report
-
Jeffs’ Brands Enters Into a Definitive Agreement to Sell Key U.S. Assets to a Canadian Public Company for an Approximate Valuation of $11.8 Million
-
Jeffs’ Brands Enters Into a Definitive Agreement to Sell Key U.S. Assets to a Canadian Public Company for an Approximate Valuation of $11.8 Million
-
BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified
-
Context Therapeutics Presents Preclinical and Translational Data for CT-95, a Mesothelin Targeting T Cell Engager, at 2025 AACR Annual Meeting
-
First National Corporation Reports First Quarter 2025 Financial Results
-
DT Midstream Reports Strong First Quarter 2025 Results
-
Stallion Uranium Announces Completion of Ground Gravity Survey over Coyote Target
-
Caliber Announces Reverse Stock Split Effective May 2, 2025
-
Altimmune to Participate in the Citizens Life Sciences Conference
-
Quoin Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
-
Apertura Gene Therapy and Rett Syndrome Research Trust Collaborate to Pioneer Advanced Genetic Medicines for Rett Syndrome Using TfR1-Targeted AAV Capsid
-
InflaRx to Report First Quarter 2025 Results on May 7, 2025
-
TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update

